The ameliorative potential of metformin against aluminum‐induced neurotoxicity: Insights from in vitro studies
Journal of Applied Toxicology · 2025-02 · 45 (2) · 245-255
DOI: 10.1002/jat.4695 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Toxicology, online erschienen am 14.09.2024. Verfasst von Sonia Sanajou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Hacettepe University, Ankara, Turkey. Hauptthemen laut MEDLINE: Metformin, Aluminum, Neurotoxicity Syndromes, Neuroprotective Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Hacettepe University Research Fund.
Abstract (Originalsprache)
Alzheimer's disease (AD) is increasingly recognized as a metabolic disorder, often referred to as type 3 diabetes, due to its strong association with insulin resistance. Chronic exposure to aluminum, a known neurotoxin, has been identified as a significant risk factor in the development and progression of AD. This study explores the potential of metformin, a common anti‐diabetic drug, to mitigate aluminum‐induced neurotoxicity in an in vitro model of AD. Our findings reveal that metformin significantly reduces oxidative stress markers such as malonaldehyde, carbonyl groups, and reactive oxygen species while enhancing antioxidant defenses. Metformin modulates critical signaling pathways, including glycogen synthase kinase 3 beta (GSK3‐β)/RAC‐alpha serine/threonine protein kinase (RAC‐alpha serine/threonine protein kinase (Akt1)/protein phosphatase 2A (PP2A) and Wnt/β‐catenin, decreasing Tau protein levels and promoting neurogenesis. These results suggest that metformin may offer a novel therapeutic approach for AD, particularly in cases where aluminum exposure is a contributing factor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Hacettepe University, Ankara, Turkey.
- Faculty of Pharmacy, Department of Toxicology, Istanbul Aydin University, Istanbul, Turkey.
- Faculty of Pharmacy, Department of Toxicology, Cukurova University, Adana, Turkey.
ORCID-Profile: Sonia Sanajou, Anil Yirün, Göksun Demirel, Pinar Erkekoğlu, Gönül Şahin, Terken Baydar
Förderung
- Hacettepe University Research Fund
Zitieren
APA
Sanajou, S., Yirün, A., Demirel, G., Erkekoğlu, P., Şahin, G., & Baydar, T. (2025). The ameliorative potential of metformin against aluminum‐induced neurotoxicity: Insights from in vitro studies. Journal of Applied Toxicology, 45(2), 245-255. https://doi.org/10.1002/jat.4695
Vancouver
Sanajou S, Yirün A, Demirel G, Erkekoğlu P, Şahin G, Baydar T. The ameliorative potential of metformin against aluminum‐induced neurotoxicity: Insights from in vitro studies. Journal of Applied Toxicology. 2025;45(2):245-255. doi:10.1002/jat.4695
BibTeX
@article{Sanajou2025,
author = {Sanajou, Sonia and Yirün, Anil and Demirel, Göksun and Erkekoğlu, Pinar and Şahin, Gönül and Baydar, Terken},
title = {The ameliorative potential of metformin against aluminum‐induced neurotoxicity: Insights from in vitro studies},
journal = {Journal of Applied Toxicology},
year = {2025},
volume = {45},
number = {2},
pages = {245--255},
doi = {10.1002/jat.4695}
}
EUVIMED